Based on 4 analysts
In the current month, SRTA has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SRTA average Analyst price target in the last month is 9.563.
Based on analysts' estimates, SRTA EPS is projected to reach 0.005 in FY2026Q3, following reported EPS of -0.122 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.12, while Strata Critical Medical Ord Shs Class ASRTA's earnings per share (EPS) for the previous quarter was USD 0.03. EPS for the next quarter is expected at USD 0.01.